Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Pharma Supply Chain: Master Data Exchange in 2021

The exchange of data needs to move from today’s manual processes to automated operations. Experts recap current progress, challenges, and what a “happy path” looks like.

Traceability comes with challenges including master data exchange.
Traceability comes with challenges including master data exchange.

In order to arrive at the unit-level traceability sought by the Drug Supply Chain Security Act (DSCSA) by its 2023 deadline, the pharmaceutical industry as a whole must tackle the issue of interoperable systems to share data with trading partners.

The overall goal of DSCSA legislation is to verify product legitimacy, make recalls more efficient, and enhance detection of illegitimate products in the supply chain. A major component of this is the requirement of serialization, the practice of assigning a unique serial number linked to product data—product origin, batch number, and expiration date—to each saleable unit of each prescription drug product. 


Read article   Just starting out? Read Serialization 101.


“But the exchange of master data today is a manual process,” explained Allison Sheldon, senior manager, Pfizer Digital Serialization, Pfizer Inc. at a recent HDA Traceability Webinar event. Serialization data is manually pulled from internal systems, and spreadsheets are maintained and emailed back and forth to trading partners.

Part of what manufacturers are trying to sort out now is how their trading partners are managing data on their end. “Are they taking HDA’s forms and applying changes that are required in their systems? How do we keep that data up to date? We'll see that when there's any type of mismatch, that creates failures when we're exchanging our serialized data. It's certainly not sustainable—we need to come to an automated approach,” said Sheldon.

Panelists offered resources for those starting out. (Credit: HDA)Panelists offered resources for those starting out. (Credit: HDA)

Brad Pine, vice president, brand pharma & regulatory at Smith Drug Company, Div. J M Smith Corporation, agreed. “Everybody gets HDA spreadsheets and adds the GTIN [Global Trade Identification Number]—it's still not very well-adopted. You’re constantly sending them back to manufacturers and saying, ‘You didn't have the GTIN on here.’ Then loading information from a spreadsheet is painstaking and it's prone to errors because of the formatting. If I don’t capture lead zeros correctly, there are issues with that.” 


Read article   Read more on GTINs and case packaging here.


EPCIS onboarding

The answer, panelists said, lies in pharma manufacturers using a common framework to exchange data: EPCIS (Electronic Product Code Information Services) files.

EPCIS is a global GS1 Standard for creating and sharing visibility event data, both within and across enterprises, to enable users to gain a shared view of physical (or digital) objects. Physical objects include products, logistics units, documents, and more, while digital objects can refer to items such as music downloads, e-books, and e-coupons.

Adoption is off to a rocky start. “Our biggest challenge is finding manufacturers that are willing to send us EPCIS events and get that onboarded,” said Pine. In a best-case scenario, Sheldon offered a chart showing that it takes around six weeks to onboard, covering three main activities:

  • Exchanging master data
  • Testing
  • Moving into production

EPCIS onboarding timeline for manufacturers (Adapted from chart presented at HDA Traceability Webinar).EPCIS onboarding timeline for manufacturers (Adapted from chart presented at HDA Traceability Webinar).

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report